Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 64 articles:
HTML format
Text format



Single Articles


    November 2017
  1. TANG YC, Zhang Y, Zhou J, Zhi Q, et al
    Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.
    Int J Oncol. 2017 Nov 1. doi: 10.3892/ijo.2017.4183.
    PubMed     Text format     Abstract available


  2. IZDEBSKA M, Gagat M, Grzanka A
    Overexpression of lamin B1 induces mitotic catastrophe in colon cancer LoVo cells and is associated with worse clinical outcomes.
    Int J Oncol. 2017 Nov 1. doi: 10.3892/ijo.2017.4182.
    PubMed     Text format     Abstract available


    October 2017
  3. DACHINENI R, Kumar DR, Callegari E, Kesharwani SS, et al
    Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.
    Int J Oncol. 2017 Oct 19. doi: 10.3892/ijo.2017.4167.
    PubMed     Text format     Abstract available


  4. KIM SL, Park YR, Lee ST, Kim SW, et al
    Parthenolide suppresses hypoxia-inducible factor-1alpha signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer.
    Int J Oncol. 2017 Oct 18. doi: 10.3892/ijo.2017.4166.
    PubMed     Text format     Abstract available


  5. LIU K, Li J, Wu X, Chen M, et al
    GSK-3beta inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells.
    Int J Oncol. 2017 Oct 16. doi: 10.3892/ijo.2017.4163.
    PubMed     Text format     Abstract available


  6. JIANG D, Li J, Li J, Wang M, et al
    Combination of FGFR4 inhibitor Blu9931 and 5-fluorouracil effects on the biological characteristics of colorectal cancer cells.
    Int J Oncol. 2017 Oct 2. doi: 10.3892/ijo.2017.4143.
    PubMed     Text format     Abstract available


  7. LEE YJ, Kang YR, Lee SY, Jin Y, et al
    Ginkgetin induces G2-phase arrest in HCT116 colon cancer cells through the modulation of bMyb and miRNA34a expression.
    Int J Oncol. 2017;51:1331-1342.
    PubMed     Text format     Abstract available


    September 2017
  8. TEO WH, Chen HP, Huang JC, Chan YJ, et al
    Human cytomegalovirus infection enhances cell proliferation, migration and upregulation of EMT markers in colorectal cancer-derived stem cell-like cells.
    Int J Oncol. 2017 Sep 25. doi: 10.3892/ijo.2017.4135.
    PubMed     Text format     Abstract available


  9. SZARYNSKA M, Olejniczak A, Wierzbicki P, Kobiela J, et al
    FasR and FasL in colorectal cancer.
    Int J Oncol. 2017;51:975-986.
    PubMed     Text format     Abstract available


    August 2017
  10. KANG KA, Piao MJ, Ryu YS, Hyun YJ, et al
    Luteolin induces apoptotic cell death via antioxidant activity in human colon cancer cells.
    Int J Oncol. 2017 Aug 2. doi: 10.3892/ijo.2017.4091.
    PubMed     Text format     Abstract available


  11. XU H, Zeng Y, Liu L, Gao Q, et al
    PRL-3 improves colorectal cancer cell proliferation and invasion through IL-8 mediated glycolysis metabolism.
    Int J Oncol. 2017 Aug 2. doi: 10.3892/ijo.2017.4090.
    PubMed     Text format     Abstract available


    July 2017
  12. PARK SY, Oh HH, Park YL, Yu HM, et al
    Malformin A1 treatment alters invasive and oncogenic phenotypes of human colorectal cancer cells through stimulation of the p38 signaling pathway.
    Int J Oncol. 2017 Jul 10. doi: 10.3892/ijo.2017.4070.
    PubMed     Text format     Abstract available


  13. XIANG S, Xiang T, Xiao Q, Li Y, et al
    Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/beta-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer.
    Int J Oncol. 2017 Jul 4. doi: 10.3892/ijo.2017.4064.
    PubMed     Text format     Abstract available


    June 2017
  14. WANG S, Shen Y, Qiu R, Chen Z, et al
    18 beta-glycyrrhetinic acid exhibits potent antitumor effects against colorectal cancer via inhibition of cell proliferation and migration.
    Int J Oncol. 2017 Jun 27. doi: 10.3892/ijo.2017.4059.
    PubMed     Text format     Abstract available


  15. CUSIMANO A, Balasus D, Azzolina A, Augello G, et al
    Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation.
    Int J Oncol. 2017 Jun 21. doi: 10.3892/ijo.2017.4049.
    PubMed     Text format     Abstract available


  16. FANG X, Hu T, Yin H, Yang J, et al
    Differences in telomerase activity and the effects of AZT in aneuploid and euploid cells in colon cancer.
    Int J Oncol. 2017 Jun 14. doi: 10.3892/ijo.2017.4043.
    PubMed     Text format     Abstract available


  17. YANG Y, Wang G, Zhu D, Huang Y, et al
    Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer.
    Int J Oncol. 2017 Jun 14. doi: 10.3892/ijo.2017.4044.
    PubMed     Text format     Abstract available


  18. ZHENG J, He S, Qi J, Wang X, et al
    Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo.
    Int J Oncol. 2017 Jun 13. doi: 10.3892/ijo.2017.4040.
    PubMed     Text format     Abstract available


    May 2017
  19. KIM JT, Weiss HL, Evers BM
    Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells.
    Int J Oncol. 2017 May 9. doi: 10.3892/ijo.2017.3990.
    PubMed     Text format     Abstract available


  20. LI H, Li D, Meng N
    Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells.
    Int J Oncol. 2017 May 8. doi: 10.3892/ijo.2017.3988.
    PubMed     Text format     Abstract available


  21. WANG Y, Sun N, Lu C, Bei Y, et al
    Upregulation of circadian gene 'hClock' contribution to metastasis of colorectal cancer.
    Int J Oncol. 2017 May 8. doi: 10.3892/ijo.2017.3987.
    PubMed     Text format     Abstract available


  22. ZHANG M, Ma F, Xie R, Wu Y, et al
    Overexpression of Srcin1 contributes to the growth and metastasis of colorectal cancer.
    Int J Oncol. 2017;50:1555-1566.
    PubMed     Text format     Abstract available


  23. CAO Y, Lin M, Bu Y, Ling H, et al
    p53-inducible long non-coding RNA PICART1 mediates cancer cell proliferation and migration.
    Int J Oncol. 2017;50:1671-1682.
    PubMed     Text format     Abstract available


    March 2017
  24. YANG Q, Wang X, Tang C, Chen X, et al
    H19 promotes the migration and invasion of colon cancer by sponging miR-138 to upregulate the expression of HMGA1.
    Int J Oncol. 2017 Mar 29. doi: 10.3892/ijo.2017.3941.
    PubMed     Text format     Abstract available


  25. NA K, Li K, Sang T, Wu K, et al
    Anticarcinogenic effects of water extract of sporoderm-broken spores of Ganoderma lucidum on colorectal cancer in vitro and in vivo.
    Int J Oncol. 2017 Mar 29. doi: 10.3892/ijo.2017.3939.
    PubMed     Text format     Abstract available


  26. GONG H, Cao Y, Han G, Zhang Y, et al
    p53/microRNA-374b/AKT1 regulates colorectal cancer cell apoptosis in response to DNA damage.
    Int J Oncol. 2017 Mar 21. doi: 10.3892/ijo.2017.3922.
    PubMed     Text format     Abstract available


    February 2017
  27. CHEN QZ, Li Y, Shao Y, Zeng YH, et al
    TGF-beta1/PTEN/PI3K signaling plays a critical role in the anti-proliferation effect of tetrandrine in human colon cancer cells.
    Int J Oncol. 2017 Feb 13. doi: 10.3892/ijo.2017.3875.
    PubMed     Text format     Abstract available


  28. LU CC, Chu PY, Hsia SM, Wu CH, et al
    Insulin induction instigates cell proliferation and metastasis in human colorectal cancer cells.
    Int J Oncol. 2017;50:736-744.
    PubMed     Text format     Abstract available


  29. ZHAO J, Li G, Bo W, Zhou Y, et al
    Multiple effects of ellagic acid on human colorectal carcinoma cells identified by gene expression profile analysis.
    Int J Oncol. 2017;50:613-621.
    PubMed     Text format     Abstract available


    January 2017
  30. LEE SY, Kim KA, Kim CH, Kim YJ, et al
    CD44-shRNA recombinant adenovirus inhibits cell proliferation, invasion, and migration, and promotes apoptosis in HCT116 colon cancer cells.
    Int J Oncol. 2017;50:329-336.
    PubMed     Text format     Abstract available


  31. FUJII K, Luo Y, Fujiwara-Tani R, Kishi S, et al
    Pro-metastatic intracellular signaling of the elaidic trans fatty acid.
    Int J Oncol. 2017;50:85-92.
    PubMed     Text format     Abstract available


  32. NGUYEN HA, Kim SA
    2'-Hydroxycinnamaldehyde induces apoptosis through HSF1-mediated BAG3 expression.
    Int J Oncol. 2017;50:283-289.
    PubMed     Text format     Abstract available


  33. LIU K, Tang Z, Huang A, Chen P, et al
    Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression.
    Int J Oncol. 2017;50:252-262.
    PubMed     Text format     Abstract available


    December 2016
  34. KAWAI K, Uemura M, Munakata K, Takahashi H, et al
    Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
    Int J Oncol. 2016 Dec 20. doi: 10.3892/ijo.2016.3814.
    PubMed     Text format     Abstract available


  35. HATA T, Mokutani Y, Takahashi H, Inoue A, et al
    Identification of microRNA-487b as a negative regulator of liver metastasis by regulation of KRAS in colorectal cancer.
    Int J Oncol. 2016 Dec 20. doi: 10.3892/ijo.2016.3813.
    PubMed     Text format     Abstract available


  36. YU H, Zhang H, Dong M, Wu Z, et al
    Metabolic reprogramming and AMPKalpha1 pathway activation by caulerpin in colorectal cancer cells.
    Int J Oncol. 2016 Dec 6. doi: 10.3892/ijo.2016.3794.
    PubMed     Text format     Abstract available


    November 2016
  37. HAGGBLAD SAHLBERG S, Mortensen AC, Haglof J, Engskog MK, et al
    Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells.
    Int J Oncol. 2016 Nov 18. doi: 10.3892/ijo.2016.3771.
    PubMed     Text format     Abstract available


  38. BAIK IH, Jo GH, Seo D, Ko MJ, et al
    Knockdown of RPL9 expression inhibits colorectal carcinoma growth via the inactivation of Id-1/NF-kappaB signaling axis.
    Int J Oncol. 2016;49:1953-1962.
    PubMed     Text format     Abstract available


    October 2016
  39. EL KHOURY F, Corcos L, Durand S, Simon B, et al
    Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
    Int J Oncol. 2016 Oct 7. doi: 10.3892/ijo.2016.3725.
    PubMed     Text format     Abstract available


  40. GAO B, Shao Q, Choudhry H, Marcus V, et al
    [Corrigendum] Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs.
    Int J Oncol. 2016 Oct 6. doi: 10.3892/ijo.2016.3722.
    PubMed     Text format     Abstract available


  41. YI H, Ji D, Zhan T, Yao Y, et al
    Prognostic value of pigment epithelium-derived factor for neoadjuvant radiation therapy in patients with locally advanced rectal carcinoma.
    Int J Oncol. 2016;49:1415-26.
    PubMed     Text format     Abstract available


    September 2016
  42. YAMAMOTO H, Oshiro R, Ohtsuka M, Uemura M, et al
    [Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies.
    Int J Oncol. 2016 Sep 16. doi: 10.3892/ijo.2016.3694.
    PubMed     Text format     Abstract available


  43. PARK GB, Chung YH, Gong JH, Jin DH, et al
    GSK-3beta-mediated fatty acid synthesis enhances epithelial to mesenchymal transition of TLR4-activated colorectal cancer cells through regulation of TAp63.
    Int J Oncol. 2016 Sep 5. doi: 10.3892/ijo.2016.3679.
    PubMed     Text format     Abstract available


  44. LIANG F, Li Q, Li X, Li Z, et al
    TSC22D2 interacts with PKM2 and inhibits cell growth in colorectal cancer.
    Int J Oncol. 2016;49:1046-56.
    PubMed     Text format     Abstract available


  45. GAO B, Shao Q, Choudhry H, Marcus V, et al
    Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs.
    Int J Oncol. 2016;49:1108-18.
    PubMed     Text format     Abstract available


  46. MUTO Y, Suzuki K, Kato T, Tsujinaka S, et al
    Heterogeneous expression of zinc-finger E-box-binding homeobox 1 plays a pivotal role in metastasis via regulation of miR-200c in epithelial-mesenchymal transition.
    Int J Oncol. 2016;49:1057-67.
    PubMed     Text format     Abstract available


    August 2016
  47. WANG W, Liu J, Qi J, Zhang J, et al
    Downregulation of RLIP76 is associated with vincristine resistance in human colorectal cancer HCT-8/VCR cells.
    Int J Oncol. 2016 Aug 23. doi: 10.3892/ijo.2016.3672.
    PubMed     Text format     Abstract available


  48. LIU WM, Scott KA, Dennis JL, Kaminska E, et al
    Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapy.
    Int J Oncol. 2016;49:793-802.
    PubMed     Text format     Abstract available


  49. SONG GL, Jin CC, Zhao W, Tang Y, et al
    Regulation of the RhoA/ROCK/AKT/beta-catenin pathway by arginine-specific ADP-ribosytransferases 1 promotes migration and epithelial-mesenchymal transition in colon carcinoma.
    Int J Oncol. 2016;49:646-56.
    PubMed     Text format     Abstract available


  50. CHUNG SS, Oliva B, Dwabe S, Vadgama JV, et al
    Combination treatment with flavonoid morin and telomerase inhibitor MST312 reduces cancer stem cell traits by targeting STAT3 and telomerase.
    Int J Oncol. 2016;49:487-98.
    PubMed     Text format     Abstract available


    July 2016
  51. XIAO Y, Zheng X, Huang A, Liu T, et al
    Deficiency of 53BP1 inhibits the radiosensitivity of colorectal cancer.
    Int J Oncol. 2016 Jul 25. doi: 10.3892/ijo.2016.3629.
    PubMed     Text format     Abstract available


  52. YU Y, Yu X, Ma J, Tong Y, et al
    Effects of NVP-BEZ235 on the proliferation, migration, apoptosis and autophagy in HT-29 human colorectal adenocarcinoma cells.
    Int J Oncol. 2016;49:285-93.
    PubMed     Text format     Abstract available


  53. ISOZAKI T, Fujita M, Yamada S, Imadome K, et al
    Effects of carbon ion irradiation and X-ray irradiation on the ubiquitylated protein accumulation.
    Int J Oncol. 2016;49:144-52.
    PubMed     Text format     Abstract available


    June 2016
  54. KIM GT, Lee SH, Kim YM
    Torilis japonica extract-generated intracellular ROS induces apoptosis by reducing the mitochondrial membrane potential via regulation of the AMPK-p38 MAPK signaling pathway in HCT116 colon cancer.
    Int J Oncol. 2016 Jun 16. doi: 10.3892/ijo.2016.3578.
    PubMed     Text format     Abstract available


  55. LIN CL, Hsieh SL, Leung W, Jeng JH, et al
    2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside suppresses human colorectal cancer cell metastasis through inhibiting NF-kappaB activation.
    Int J Oncol. 2016 Jun 9. doi: 10.3892/ijo.2016.3574.
    PubMed     Text format     Abstract available


  56. LU M, Wang C, Wang J
    Tanshinone I induces human colorectal cancer cell apoptosis: The potential roles of Aurora A-p53 and survivin-mediated signaling pathways.
    Int J Oncol. 2016 Jun 7. doi: 10.3892/ijo.2016.3565.
    PubMed     Text format     Abstract available


  57. ESPOSITO G, Gigli S, Seguella L, Nobile N, et al
    Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway.
    Int J Oncol. 2016 Jun 1. doi: 10.3892/ijo.2016.3550.
    PubMed     Text format     Abstract available


  58. GALATEANU B, Hudita A, Negrei C, Ion RM, et al
    Impact of multicellular tumor spheroids as an in vivolike tumor model on anticancer drug response.
    Int J Oncol. 2016;48:2295-302.
    PubMed     Text format     Abstract available


  59. ORLANDO A, Linsalata M, Russo F
    Antiproliferative effects on colon adenocarcinoma cells induced by co-administration of vitamin K1 and Lactobacillus rhamnosus GG.
    Int J Oncol. 2016;48:2629-38.
    PubMed     Text format     Abstract available


    April 2016
  60. BASAK D, Punganuru SR, Srivenugopal KS
    Piperlongumine exerts cytotoxic effects against cancer cells with mutant p53 proteins at least in part by restoring the biological functions of the tumor suppressor.
    Int J Oncol. 2016;48:1426-36.
    PubMed     Text format     Abstract available


    February 2016
  61. YOSHIOKA S, Mitsuyama K, Takedatsu H, Kuwaki K, et al
    Advanced endoscopic features of ulcerative colitis-associated neoplasias: Quantification of autofluorescence imaging.
    Int J Oncol. 2016;48:551-8.
    PubMed     Text format     Abstract available


  62. WOJAS-TUREK J, Szczygiel A, Kicielinska J, Rossowska J, et al
    Treatment with cyclophosphamide supported by various dendritic cell-based vaccines induces diversification in CD4(+) T cell response against MC38 colon carcinoma.
    Int J Oncol. 2016;48:493-505.
    PubMed     Text format     Abstract available


    January 2016
  63. TAKAHASHI H, Suzuki Y, Nishimura J, Haraguchi N, et al
    Characteristics of carbonic anhydrase 9 expressing cells in human intestinal crypt base.
    Int J Oncol. 2016;48:115-22.
    PubMed     Text format     Abstract available


    September 2015
  64. FUNAMIZU N, Lacy CR, Kamada M, Yanaga K, et al
    MicroRNA-203 induces apoptosis by upregulating Puma expression in colon and lung cancer cells.
    Int J Oncol. 2015 Sep 22. doi: 10.3892/ijo.2015.3178.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: